Cargando…

The selective serotonin reuptake inhibitor fluoxetine has direct effects on beta cells, promoting insulin secretion and increasing beta‐cell mass

AIM: This study investigated whether therapeutically relevant concentrations of fluoxetine, which have been shown to reduce plasma glucose and glycated haemoglobin independent of changes in food intake and body weight, regulate beta‐cell function and improve glucose homeostasis. METHODS: Cell viabil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Bo, Ruz‐Maldonado, Inmaculada, Toczyska, Klaudia, Olaniru, Oladapo E., Zariwala, Mohammed Gulrez, Hopkins, David, Zhao, Min, Persaud, Shanta J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545812/ https://www.ncbi.nlm.nih.gov/pubmed/35676820 http://dx.doi.org/10.1111/dom.14791

Ejemplares similares

Using single‐cell multi‐omics screening of human fetal pancreas to identify novel players in human beta cell development
por: Olaniru, Oladapo E., et al.
Publicado: (2022)

Selective serotonin reuptake inhibitor, fluoxetine, impairs E-cadherin-mediated cell adhesion and alters calcium homeostasis in pancreatic beta cells
por: Chang, Huang-Yu, et al.
Publicado: (2017)

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
por: Kobayashi, Katsunori, et al.
Publicado: (2011)

Treatment with the selective serotonin reuptake inhibitor, fluoxetine, attenuates the fish hypoxia response
por: Panlilio, Jennifer M., et al.
Publicado: (2016)

Effects of a Selective Serotonin Reuptake Inhibitor, Fluoxetine, on Counterregulatory Responses to Hypoglycemia in Healthy Individuals
por: Briscoe, Vanessa J., et al.
Publicado: (2008)

In utero and lactational exposure to the Selective Serotonin Reuptake Inhibitor fluoxetine compromises pup bones at weaning
por: Weaver, Samantha R., et al.
Publicado: (2019)

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
por: Zimniak, Melissa, et al.
Publicado: (2021)

Effects of the Selective Serotonin Reuptake Inhibitor Fluoxetine on Counterregulatory Responses to Hypoglycemia in Individuals With Type 1 Diabetes
por: Briscoe, Vanessa J., et al.
Publicado: (2008)

Cellular Correlates of Enhanced Anxiety Caused by Acute Treatment with the Selective Serotonin Reuptake Inhibitor Fluoxetine in Rats
por: Ravinder, Shilpa, et al.
Publicado: (2011)

Excessive Iron Induces Oxidative Stress Promoting Cellular Perturbations and Insulin Secretory Dysfunction in MIN6 Beta Cells
por: Blesia, Voni, et al.
Publicado: (2021)

The adhesion receptor GPR56 is activated by extracellular matrix collagen III to improve β-cell function
por: Olaniru, Oladapo E., et al.
Publicado: (2018)

Effects of the Selective Serotonin Reuptake Inhibitor Fluoxetine on Developing Neural Circuits in a Model of the Human Fetal Cortex
por: Tate, Kinsley, et al.
Publicado: (2021)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Obligatory roles of dopamine D1 receptors in the dentate gyrus in antidepressant actions of a selective serotonin reuptake inhibitor, fluoxetine
por: Shuto, Takahide, et al.
Publicado: (2018)

Direct Stimulatory Effects of the CB(2) Ligand JTE 907 in Human and Mouse Islets
por: Ruz-Maldonado, Inmaculada, et al.
Publicado: (2021)

Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine
por: Yang, Huaiyu, et al.
Publicado: (2010)

The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer’s disease and vascular dementia: focusing on fluoxetine with long follow-up periods
por: Xie, Yi, et al.
Publicado: (2019)

Fluoxetine, a selective serotonin reuptake inhibitor used clinically, improves bladder function in a mouse model of moderate spinal cord injury
por: Ma, Long, et al.
Publicado: (2021)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular Dysregulation
por: Ungvari, Zoltan, et al.
Publicado: (2019)

Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine
por: Luong, Thu-Lan T., et al.
Publicado: (2022)

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)

Periodontal and peri-implant status and whole salivary interleukin 1-beta levels among individuals using selective serotonin reuptake inhibitors: an observational study
por: ALHarthi, Shatha Subhi, et al.
Publicado: (2023)

Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate
por: Takenaka, Yohei, et al.
Publicado: (2022)

Imatinib prevents beta cell death in vitro but does not improve islet transplantation outcome
por: King, Aileen J. F., et al.
Publicado: (2016)

Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose
por: Little, Kimberly, et al.
Publicado: (2018)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
por: Pleym, Hilde, et al.
Publicado: (2011)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Selective serotonin reuptake inhibitor-induced cell death: in search of a mechanism
por: Glöckel, Christina, et al.
Publicado: (2010)

SNAP-tag-enabled super-resolution imaging reveals constitutive and agonist-dependent trafficking of GPR56 in pancreatic β-cells
por: Olaniru, Oladapo E., et al.
Publicado: (2021)

Long and Short Duration Exposures to the Selective Serotonin Reuptake Inhibitors (SSRIs) Fluoxetine, Paroxetine and Sertraline at Environmentally Relevant Concentrations Lead to Adverse Effects on Zebrafish Behaviour and Reproduction
por: Venkatachalam, Ananda Baskaran, et al.
Publicado: (2023)

Safety and Efficacy of Drug Holidays for Women with Sexual Dysfunction Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) Other than Fluoxetine: An Open-Label Randomized Clinical Trial
por: Lalegani, Elham, et al.
Publicado: (2023)

Developmental Exposure to Fluoxetine Modulates the Serotonin System in Hypothalamus
por: Berg, Cecilia, et al.
Publicado: (2013)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

C3aR and C5aR1 act as key regulators of human and mouse β-cell function
por: Atanes, Patricio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jvc0n5bu3rt5u2a5i49qigife1